EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients

Yong Liu, Wencai Wu, Yunping Xiao, Hongyan Zou, Sijia Hao, Yanfang Jiang

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1439472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Yong Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Immunocompromised Host, High-Throughput Nucleotide Sequencing, Metagenomics, Bronchoalveolar Lavage Fluid. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metagenomic next-generation sequencing (mNGS) technology has been widely used to diagnose various infections. Based on the most common pathogen profiles, targeted mNGS (tNGS) using multiplex PCR has been developed to detect pathogens with predesigned primers in the panel, significantly improving sensitivity and reducing economic burden on patients. However, there are few studies on summarizing pathogen profiles of pulmonary infections in immunocompetent and immunocompromised patients in Jilin Province of China on large scale.

Methods

From January 2021 to December 2023, bronchoalveolar lavage fluid (BALF) or sputum samples from 546 immunocompetent and immunocompromised patients with suspected community-acquired pneumonia were collected. Pathogen profiles in those patients on whom mNGS was performed were summarized. Additionally, we also evaluated the performance of tNGS in diagnosing pulmonary infections.

Results

Combined with results of mNGS and culture, we found that the most common bacterial pathogens were Pseudomonas aeruginosa , Klebsiella pneumoniae , and Acinetobacter baumannii in both immunocompromised and immunocompetent patients with high detection rates of Staphylococcus aureus and Enterococcus faecium , respectively. For fungal pathogens, Pneumocystis jirovecii was commonly detected in patients, while fungal infections in immunocompetent patients were mainly caused by Candida albicans . Most of viral infections in patients were caused by Human betaherpesvirus 5 and Human gammaherpesvirus 4. It is worth noting that, compared with immunocompetent patients (34.9%, 76/218), more mixed infections were found in immunocompromised patients (37.8%, 14/37). Additionally, taking final comprehensive clinical diagnoses as reference standard, total coincidence rate of BALF tNGS (81.4%, 48/59) was much higher than that of BALF mNGS (40.0%, 112/280).

Conclusions

Our findings supplemented and classified the pathogen profiles of pulmonary infections in immunocompetent and immunocompromised patients in Jilin Province of China. Most importantly, our findings can accelerate the development and design of tNGS specifically used for regional pulmonary infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunocompromised HostHigh-Throughput Nucleotide SequencingMetagenomicsBronchoalveolar Lavage FluidHumansMaleFemaleMiddle AgedChinaAdultAgedYoung AdultBacteriaSputumCommunity-Acquired InfectionsAdolescentImmunocompetencePneumoniaAged, 80 and over

Stichwörter der Autor:innen

MNGsTNGSbronchoalveolar lavage fluidimmunocompetent and immunocompromisedpulmonary infection

Autor:innen und Institutionen

  • Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, China.
  • Key Laboratory of Biomedical Information Engineering of Ministry of Education, Biomedical Informatics & Genomics Center, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Zitieren

APA

Liu, Y., Wu, W., Xiao, Y., Zou, H., Hao, S., & Jiang, Y. (2024). Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1439472

Vancouver

Liu Y, Wu W, Xiao Y, Zou H, Hao S, Jiang Y. Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1439472

BibTeX
@article{Liu2024,
  author = {Liu, Yong and Wu, Wencai and Xiao, Yunping and Zou, Hongyan and Hao, Sijia and Jiang, Yanfang},
  title = {Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1439472}
}
Kostenlos starten →